Livalo and Cataract - a phase IV clinical study of FDA data
Summary:
Cataract is reported as a side effect among people who take Livalo (pitavastatin calcium), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Singulair, and have Immunodeficiency common variable.
The phase IV clinical study analyzes which people have Cataract when taking Livalo. It is created by eHealthMe based on reports of 8,536 people who have side effects when taking Livalo from the FDA, and is updated regularly.
What is Livalo?
Livalo has active ingredients of pitavastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 8,802 Livalo users. Check the latest studies of Livalo.
What is Cataract?
Cataract (clouding of the lens inside the eye) is found to be associated with 1,892 drugs and 2,133 conditions by eHealthMe. Check the latest studies of Cataract.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
8,536 people reported to have side effects when taking Livalo.
Among them, 72 people (0.84%) have Cataract.

Among these 72 people:
How long have people been on Livalo when they have Cataract? *
- < 1 month: 25 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 50 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 25 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Cataract when taking Livalo? *
- female: 42.42 %
- male: 57.58 %
What is the age of people who have Cataract when taking Livalo? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 1.89 %
- 50-59: 5.66 %
- 60+: 92.45 %
What are other drugs people take besides Livalo? *
- Singulair: 21 people, 29.17%
- Symbicort: 17 people, 23.61%
- Celebrex: 16 people, 22.22%
- Acetaminophen: 15 people, 20.83%
- Epinephrine: 15 people, 20.83%
- Tylenol: 13 people, 18.06%
- Nexium: 13 people, 18.06%
- Lidocaine: 12 people, 16.67%
- Gabapentin: 12 people, 16.67%
- Plavix: 11 people, 15.28%
What are other side effects people have besides Cataract? *
- Headache (pain in head): 19 people, 26.39%
- Weakness: 13 people, 18.06%
- Dizziness: 13 people, 18.06%
- Pain: 9 people, 12.50%
- Cardiac Disorder: 9 people, 12.50%
- Itching: 9 people, 12.50%
- Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 9 people, 12.50%
- Lung Disorder (lung disease): 9 people, 12.50%
- Diarrhea: 9 people, 12.50%
- Parkinson's Disease: 9 people, 12.50%
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 14 people, 19.44%
- High Blood Pressure: 13 people, 18.06%
- Osteoporosis (bones weak and more likely to break): 10 people, 13.89%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 9.72%
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 7 people, 9.72%
- Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 7 people, 9.72%
- Upper Respiratory Tract Inflammation: 5 people, 6.94%
- Diabetes: 5 people, 6.94%
- Conjunctivitis (pink eye): 5 people, 6.94%
- Cerebrovascular Disorder (disease of brain): 5 people, 6.94%
* Approximation only. Some reports may have incomplete information.
Do you take Livalo and have Cataract?
- Check whether Cataract is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Livalo:
- Livalo (8,802 reports)
Cataract treatments and more:
- Cataract (70,565 reports)
How severe was Cataract and when was it recovered:
Expand to all the drugs that have ingredients of pitavastatin calcium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Livalo:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cataract:
- Cataract (1,892 drugs)
Browse all the conditions that are associated with Cataract:
- Cataract (2,133 conditions)
Related publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on pitavastatin calcium (the active ingredients of Livalo) and Livalo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Benadryl and Acthar - now
- Could Xyrem cause Quit Smoking? - 4 seconds ago
- Could Lansoprazole cause Feeling Of Despair? - 10 seconds ago
- Could Enbrel cause Chagas Disease? - 10 seconds ago
- Epilepsy and Primary Pulmonary Hypertension - 14 seconds ago
- Could Omeprazole cause Hyperhidrosis? - 19 seconds ago
- Drug interactions of Atenolol and Accupril - 20 seconds ago
- Could Norco cause Hyperventilation? - 30 seconds ago
- Could Deferoxamine Mesylate cause Laryngitis Fungal? - 31 seconds ago
- Could Sodium Bicarbonate cause Eczema Exacerbated? - 31 seconds ago